Cogent Biosciences Inc. (COGT)
NASDAQ: COGT
· Real-Time Price · USD
7.46
0.38 (5.37%)
At close: Jun 16, 2025, 3:59 PM
7.12
-4.49%
After-hours: Jun 16, 2025, 07:55 PM EDT
Cogent Biosciences Revenue Breakdown
| Period Ending | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|
| Preclinical Research And Clinical Development Revenue | 25M | 25M |
| Preclinical Research And Clinical Development Revenue Growth | 0.00% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Sep 30, 2016 | Sep 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 11.9M | 11.69M | 11.8M | 10.09M | 9.7M | 9.51M | 9.45M | 8.21M | 7.2M | 7M | 6.88M | 6.38M | 5.95M | 5.13M | 5.02M | 4.9M | 4.59M | 5.35M | 5.6M | 2.8M | 3.67M | 2.69M | 2.72M | 3.06M | 2.49M | 2.04M | 2.37M | 1.98M | 1.06M | 1.44M | 1.32M | 971K | 944K | 21.37M | 4.7M |
| Selling, General, and Administrative Revenue Growth | +1.84% | -0.94% | +16.91% | +4.06% | +2.00% | +0.59% | +15.08% | +14.10% | +2.80% | +1.71% | +7.98% | +7.20% | +16.04% | +2.09% | +2.39% | +6.91% | -14.23% | -4.47% | +99.79% | -23.73% | +36.38% | -0.99% | -11.14% | +22.92% | +21.87% | -13.65% | +19.61% | +86.00% | -26.16% | +8.84% | +36.35% | +2.86% | -95.58% | +354.44% | n/a |
| Research and Development Revenue | 63.03M | 62.05M | 63.61M | 54.29M | 52.7M | 48.72M | 50.13M | 38.87M | 36.04M | 36.74M | 29.94M | 29.48M | 25.47M | 20.51M | 14.8M | 12.39M | 8.21M | 6.11M | 51.91M | 5.13M | 9.5M | 10.35M | 10.34M | 10.62M | 12.4M | 10.77M | 10.25M | 9.13M | 8.14M | 7.56M | 8.18M | 7.14M | 6.95M | n/a | n/a |
| Research and Development Revenue Growth | +1.59% | -2.47% | +17.17% | +3.01% | +8.18% | -2.81% | +28.96% | +7.86% | -1.92% | +22.74% | +1.55% | +15.74% | +24.16% | +38.63% | +19.45% | +50.83% | +34.49% | -88.24% | +912.15% | -46.00% | -8.27% | +0.18% | -2.66% | -14.40% | +15.22% | +5.00% | +12.34% | +12.09% | +7.67% | -7.52% | +14.51% | +2.72% | n/a | n/a | n/a |